Monday, September 28, 2020
Home Africa Goldman gave clients a list of stocks that may surge if a...

Goldman gave clients a list of stocks that may surge if a coronavirus vaccine is approved – CNBC

A view of Mickey Mouse at the Walt Disney World theme park entrance on July 9, 2020 in Lake Buena Vista, Florida.

Octavio Jones | Getty Images

(This story is only for CNBC Pro subscribers)

With several Covid-19 vaccines in Phase 3 trials and preliminary data due as soon as later this month, Goldman Sachs is preparing its clients for a rebound in certain stocks and recommending tweaks to client portfolios.

It grouped a list of several U.S. equities into four buckets.

The first bucket includes stocks that have sold off in 2020 but should bounce back as people “‘return to normal.'” The second bucket is comprised of equities that appear to have gained a competitive advantage but need their markets to reopen to capitalize.

The third are those that should bounce back when global growth recovers. And the fourth bucket are those stocks that should fare well over the long term but remain shaky in the near term, even if a vaccine is approved.

“While we take no view on when a vaccine will be approved for the virus, against this backdrop of potential catalysts ahead, we look across our US GIR coverage universe to identify a relatively short list of 19 stocks that our analysts believe could outperform once a vaccine is approved,” wrote Goldman analyst Chris Hussey. 

Read More

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisment -

Most Popular

1 in 3 parents won’t get flu shots for their child during Covid-19, study finds – CNN

(CNN)One-third of American parents have no plans to get their children vaccinated for the flu this year, according to the National Poll on Children's Health released Monday, despite the very real possibility their child could also catch the deadly Covid-19.In addition, two-thirds of parents don't believe getting a flu shot for their child is more…

Australian firm says its nasal spray reduced coronavirus growth in animal study – Yahoo News

SYDNEY (Reuters) - Australian biotech company Ena Respiratory said on Monday that a nasal spray it is developing to improve the human immune system to fight common cold and flu significantly reduced the growth of the coronavirus in a recent study on animals.A study on ferrets showed the product dubbed INNA-051, which could be used…

Eat to beat disease: The tasty ways to boost your heart and brain – Daily Mail

Inflammation is the biggest health risk we all face and it lies at the root of many of the most common and serious conditions. Here, in the second part of our life-changing new series, top dietitian Jane Clarke reveals the steps — and the recipes — to help tackle it. Wouldn’t it be awful to have to…

Dreamworld accident: Australian theme park fined over four deaths

Publishedduration1 hour agoimage copyrightAlamyimage caption(L-R) Kate Goodchild, Luke Dorsett, Roozbeh Araghi and Cindy Low died in 2016The operator of Australia's Dreamworld theme park has been fined A$3.6m (£2m; $2.5m) over the deaths of four people on a malfunctioning water ride.Kate Goodchild, Luke Dorsett, Roozbeh Araghi and Cindy Low died in October 2016 when their raft…